Dr. Mark Goldberg is an entrepreneur with a wealth of experience in drug research and as a regulatory consultant.
He served as President and CEO of GlobalTox, a privately owned international corporation that he founded in 1992 to provide services in product testing and registration, human and environmental toxicology, and risk assessment. GlobalTox was purchased by MTE Consultants Inc. in 2009.
Dr. Goldberg received a B.Sc. in biology from the University of Western Ontario in 1974 and a PhD in pharmacology from the Faculty of Medicine at Memorial University in 1980. He did his postdoctoral work in biochemical and genetic toxicology at the Ontario Cancer Institute.